1. Home
  2. STTK vs ALMU Comparison

STTK vs ALMU Comparison

Compare STTK & ALMU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$4.01

Market Cap

275.9M

Sector

Health Care

ML Signal

HOLD

Logo Aeluma Inc.

ALMU

Aeluma Inc.

HOLD

Current Price

$15.72

Market Cap

286.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
ALMU
Founded
2016
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
275.9M
286.8M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
STTK
ALMU
Price
$4.01
$15.72
Analyst Decision
Buy
Strong Buy
Analyst Count
7
2
Target Price
$6.20
$25.50
AVG Volume (30 Days)
893.1K
432.4K
Earning Date
11-06-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,000,000.00
$5,569,000.00
Revenue This Year
N/A
$20.26
Revenue Next Year
N/A
$69.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
307.21
52 Week Low
$0.69
$5.69
52 Week High
$4.89
$25.88

Technical Indicators

Market Signals
Indicator
STTK
ALMU
Relative Strength Index (RSI) 49.25 39.34
Support Level $3.92 $15.86
Resistance Level $4.46 $18.05
Average True Range (ATR) 0.35 1.70
MACD -0.12 -0.58
Stochastic Oscillator 20.64 9.28

Price Performance

Historical Comparison
STTK
ALMU

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About ALMU Aeluma Inc.

Aeluma Inc is a semiconductor company specializing in sensors and communications. It is developing sensor technology for mobile devices and vehicles. The company develops novel optoelectronic devices for sensing and communications applications. The company manufactures devices using high-performance compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass-market microelectronics. The applications include mobile, automotive, AI, defense & aerospace, communication, AR/VR and quantum computing.

Share on Social Networks: